On February 25, 2025, Solventum Corp agreed to sell its purification and filtration business to Thermo Fisher Scientific for about $4.10 billion, subject to certain conditions and adjustments. The deal includes various assets and liabilities, with expected closure by the end of 2025, pending regulatory approvals.